Metastasis to the pancreas represents a small proportion of all pancreatic malignancies.
Among primary tumors that metastasize to the pancreas, renal cell carcinoma (RCC) is one …

One of the most common and deadly types of pancreatic cancer (PC) is pancreatic ductal
adenocarcinoma (PDAC), with most patients succumbing to the disease within one year of …

Background Post‐pancreatitis diabetes mellitus (PPDM) is a common consequence of
chronic pancreatitis (CP). We aimed to determine the incidence and predictors of PPDM …

Pancreatic ductal adenocarcinoma (PDAC) presents a formidable challenge with high
lethality and limited effective drug treatments. Its heightened metastatic potential further …

Type II diabetes is associated with cancer risk in the general population but has not been
well studied as a risk factor for subsequent malignancies among cancer survivors. We …

Objectives The study aimed to investigate the added value of blood glucose monitoring in
high-risk individuals (HRIs) participating in pancreatic cancer surveillance. Methods HRIs …

Background and aims While type 2 diabetes is a well-known risk factor for pancreatic ductal
adenocarcinoma (PDAC), PDAC-induced new-onset diabetes (PDAC-NOD) is a …

This manuscript seeks to describe diagnostic considerations in individuals with diabetes
mellitus presenting to the ED with abdominal pain. It highlights the importance of early …

Background and Objectives: Glucose metabolism alterations are very common in solid
pancreatic lesions, particularly in pancreatic cancer. Similarly, diabetes and especially new …

Das Pankreasadenokarzinom (PK) nimmt stetig an Häufigkeit zu und stellt bereits die
dritthäufigste tumorbedingte Todesursache in Deutschland dar. Voraussichtlich rückt es bis …